...
首页> 外文期刊>Angewandte Chemie >Benzoxazolone Carboxamides: Potent and Systemically Active Inhibitors of Intracellular Acid Ceramidase
【24h】

Benzoxazolone Carboxamides: Potent and Systemically Active Inhibitors of Intracellular Acid Ceramidase

机译:苯并恶唑酮羧酰胺:细胞内酸性神经酰胺酶的强效和全身活性抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

The ceramides are a family of bioactive lipid-derived messengers involved in the control of cellular senescence, inflammation, and apoptosis. Ceramide hydrolysis by acid ceramidase (AC) stops the biological activity of these substances and influences survival and function of normal and neoplastic cells. Because of its central role in the ceramide metabolism, AC may offer a novel molecular target in disorders with dysfunctional ceramide-mediated signaling. Here, a class of benzoxazolone carboxamides is identified as the first potent and systemically active inhibitors of AC. Prototype members of this class inhibit AC with low nanomolar potency by covalent binding to the catalytic cysteine. Their metabolic stability and high invivo efficacy suggest that these compounds may be used as probes to investigate the roles of ceramide in health and disease, and that this scaffold may represent a promising starting point for the development of novel therapeutic agents.
机译:神经酰胺是生物活性脂质衍生的信使家族,参与细胞衰老,炎症和细胞凋亡的控制。酸性神经酰胺酶(AC)水解神经酰胺会终止这些物质的生物学活性,并影响正常细胞和肿瘤细胞的存活和功能。由于其在神经酰胺代谢中的核心作用,AC可能在神经酰胺功能紊乱的信号传导障碍中提供新的分子靶标。在这里,一类苯并恶唑酮羧酰胺被确定为AC的第一种有效的和系统活性的抑制剂。这类原型成员通过与催化半胱氨酸共价结合,以低纳摩尔浓度抑制AC。它们的代谢稳定性和高体内效力表明,这些化合物可用作研究神经酰胺在健康和疾病中作用的探针,并且该支架可能代表了开发新型治疗剂的有希望的起点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号